Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.554530
Title: Dysregulated toll-like receptor mechanisms : the cause of atherosclerosis?
Author: Gamper, Frederick
Awarding Body: University of Sussex
Current Institution: University of Sussex
Date of Award: 2011
Availability of Full Text:
Access through EThOS:
Access through Institution:
Abstract:
It is estimated that in the European Union 2 million deaths each year (42% of total) are as a result of cardiovascular disease, of which atherosclerosis is a major underlying factor. In 2006 this was estimated to cost the European Union an astonishing €192 billion. Once considered a lipid storage disorder it is becoming apparent that atherosclerosis is in fact due to an inflammatory dysfunction, with a number of endogenous and exogenous activators coming to light. The process of atheroma formation is poorly understood. This study seeks to discover the underlying mechanisms of plaque development with the view to develop novel therapeutics for this disease. Our results demonstrate a modulatory role of endogenous low density lipoprotein (LDL), “bad cholesterol”, on bacterial infections. Using primary human umbilical vein endothelial cells (HUVECs) I have shown that “non-self” oxidised LDL can reduce cell surface expression of pattern recognition receptors (PRRs) of the innate immune system, causing modulation of the cellular response directed towards atherosclerosis-associated bacterial pathogen-associated molecular patterns (PAMPs). Triple label fluorescent confocal microscopy of HUVECs revealed altered trafficking and targeting of PRRs of the innate immune system when endogenous LDL were combined with a bacterial infection in comparison to infection alone, indicating a source of the inflammatory dysfunction observed in this disease. This study illustrates that oxidatively modified LDL has a profound effect on bacterial infection, dramatically altering cellular response which may begin to explain the root cause of atherosclerosis. Through experimentation with human embryonic kidney (HEK) transfectants and HUVEC PRR silencing this study uncovered lipid raft dependant Toll-like receptors (TLRs) as fundamental culprits of this multi-factorial disease, with emphasis on TLR2 and TLR4. Future therapy designed for atherosclerosis will unquestionably involve the manipulation of TLR signalling.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.554530  DOI: Not available
Keywords: QD0415 Biochemistry ; R Medicine (General) ; RC0581 Specialties of internal medicine
Share: